Ketamine Long Therm Follow Up Study
NCT04238039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2020-01-23
Summary
Results of the study and of 5 years follow up of depressed patients who participated in the study during 2014-2015. We will locate the participants and will interview them will use the same questionnaires to evaluate their depressive symptoms. We will also measure the time to relapse.
Conditions
- Followin Ketamine Treatment
Sponsors & Collaborators
-
The Chaim Sheba Medical Center
lead OTHER
Eligibility
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-14
- Primary Completion
- 2020-02-01
- Completion
- 2020-04-01
Countries
- Israel
Study Locations
More Related Trials
-
Ketamine as an Adjunctive Therapy for Major Depression
NCT03256162 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Ketamine in Patients With Treatment-resistant Depression
NCT01627782 ·Status: COMPLETED ·Phase: PHASE2
-
Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
NCT04101474 ·Status: COMPLETED ·Phase: NA
-
Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
NCT01613820 ·Status: WITHDRAWN ·Phase: NA
-
Study of Depression-Ketamine-Brain Function
NCT01135758 ·Status: TERMINATED ·Phase: PHASE2
-
Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
NCT04239963 ·Status: COMPLETED
-
Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
NCT03742557 ·Status: UNKNOWN ·Phase: PHASE3
-
Ketamine in Adolescents With Treatment-Resistant Depression
NCT02078817 ·Status: COMPLETED ·Phase: PHASE2
-
Sustained Ketamine Effectiveness for Suicidal Ideation
NCT06806475 ·Status: COMPLETED
-
Ketamine Plus Lithium in Treatment-Resistant Depression
NCT01880593 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine As an Adjunctive Therapy for Major Depression (2)
NCT04939649 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Ketamine Effects on Functional Neuroanatomy
NCT04205890 ·Status: WITHDRAWN ·Phase: PHASE1
-
Ketamine Trial for the Treatment of Depression
NCT02401139 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
NCT01667926 ·Status: COMPLETED ·Phase: NA
-
Continuation Ketamine in Major Depression
NCT00548964 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine Treatment Plans for Chronic Conditions
NCT06038409 ·Status: RECRUITING
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT05991232 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
ED Treatment of Suicidal Patients With Ketamine Infusion
NCT03502551 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neural Circuit Effects of Ketamine in Depression
NCT06213324 ·Status: RECRUITING ·Phase: PHASE4
-
Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression
NCT05045378 ·Status: COMPLETED ·Phase: PHASE4
-
Intranasal Ketamine for Suicidal Ideation in Veterans
NCT03788694 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
NCT06232291 ·Status: COMPLETED
-
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
NCT03889756 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression
NCT06559826 ·Status: RECRUITING ·Phase: PHASE2
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
NCT06788249 ·Status: RECRUITING ·Phase: EARLY_PHASE1